ZANAFLEX CAPSULES Trademark

Trademark Overview

On Thursday, September 15, 2005, a trademark application was filed for ZANAFLEX CAPSULES with the United States Patent and Trademark Office. The USPTO has given the ZANAFLEX CAPSULES trademark a serial number of 78713378. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, November 29, 2017. This trademark is owned by Elan Pharmaceuticals, Inc.. The ZANAFLEX CAPSULES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing tizanadine hydrochloride for the treatment of neurological disorders
zanaflex capsules

General Information

Serial Number78713378
Word MarkZANAFLEX CAPSULES
Filing DateThursday, September 15, 2005
Status800 - REGISTERED AND RENEWED
Status DateWednesday, November 29, 2017
Registration Number3341341
Registration DateTuesday, November 20, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations containing tizanadine hydrochloride for the treatment of neurological disorders
Disclaimer with Predetermined Text"CAPSULES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 22, 2005
Primary Code005
First Use Anywhere DateMonday, April 4, 2005
First Use In Commerce DateMonday, April 4, 2005

Trademark Owner History

Party NameCOVIS PHARMA B.V.
Party Type31 - New Owner After Registration
Legal Entity Type26 - NOT AVAILABLE
AddressZUG
CH
Party NameAcorda Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameAcorda Therapeutics, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressHawthorne, NY 10532
Party NameElan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameElan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, January 11, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 26, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 9, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 24, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 17, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, November 29, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, November 29, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, November 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 31, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, November 20, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, November 30, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 30, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 18, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Saturday, November 30, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 18, 2013TEAS SECTION 8 & 15 RECEIVED
Wednesday, November 21, 2007ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 20, 2007REGISTERED-PRINCIPAL REGISTER
Friday, November 16, 2007ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 15, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, October 15, 2007ASSIGNED TO LIE
Thursday, September 13, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 24, 2007STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 18, 2007USE AMENDMENT FILED
Wednesday, July 18, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, February 27, 2007SOU EXTENSION 1 GRANTED
Tuesday, February 27, 2007SOU EXTENSION 1 FILED
Tuesday, February 27, 2007TEAS EXTENSION RECEIVED
Tuesday, August 29, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2006NOTICE OF PUBLICATION
Tuesday, April 18, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 18, 2006ASSIGNED TO LIE
Tuesday, March 28, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 27, 2006EXAMINER'S AMENDMENT ENTERED
Monday, March 27, 2006EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2006EXAMINERS AMENDMENT -WRITTEN
Friday, March 24, 2006ASSIGNED TO EXAMINER
Tuesday, November 8, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, October 26, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 26, 2005PAPER RECEIVED
Thursday, September 22, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

capsules zanaflex treatment neurological disorders hydrochloride tizanadine preparations containing pharmaceutical